Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Ross Stuart Berkowitz, M.D.

TitleWilliam H. Baker Professor of Gynecology
InstitutionBrigham and Women's Hospital
DepartmentObstetrics Gynecology & Repro. Bio.
AddressBrigham and Women's Hospital
Ob/Gyn
75 Francis St
Boston MA 02115
Phone617/732-8843
Fax617/738-5124

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Greer AH, Yong T, Fennell K, Moustafa YW, Fowler M, Galiano F, Ng SW, Berkowitz RS, Cardelli J, Meyers S, Davis JN. Knockdown of core binding factorß alters sphingolipid metabolism. J Cell Physiol. 2013 Dec; 228(12):2350-64.
    View in: PubMed
  2. Merritt MA, Bentink S, Schwede M, Iwanicki MP, Quackenbush J, Woo T, Agoston ES, Reinhardt F, Crum CP, Berkowitz RS, Mok SC, Witt AE, Jones MA, Wang B, Ince TA. Gene Expression Signature of Normal Cell-of-Origin Predicts Ovarian Tumor Outcomes. PLoS One. 2013; 8(11):e80314.
    View in: PubMed
  3. Lee LJ, Demaria R, Berkowitz R, Matulonis U, Viswanathan AN. Clinical predictors of long-term survival for stage IVB uterine papillary serous carcinoma confined to the abdomen. Gynecol Oncol. 2014 Jan; 132(1):65-9.
    View in: PubMed
  4. Viswanathan AN, Lee H, Berkowitz R, Berlin S, Campos S, Feltmate C, Horowitz N, Muto M, Sadow CA, Matulonis U. A prospective feasibility study of radiation and concurrent bevacizumab for recurrent endometrial cancer. Gynecol Oncol. 2014 Jan; 132(1):55-60.
    View in: PubMed
  5. Shoni M, Nagymanyoki Z, Vitonis AF, Jimenez C, Ng SW, Quade BJ, Berkowitz RS. p-21-Activated kinase-1, -4 and -6 and estrogen receptor expression pattern in normal placenta and gestational trophoblastic diseases. Gynecol Oncol. 2013 Dec; 131(3):759-63.
    View in: PubMed
  6. Zhou S, Tang L, Wang H, Dai J, Zhang J, Shen L, Ng SW, Berkowitz RS. Overexpression of c-Abl predicts unfavorable outcome in epithelial ovarian cancer. Gynecol Oncol. 2013 Oct; 131(1):69-76.
    View in: PubMed
  7. Diver E, May T, Vargas R, Bernstein M, Goldstein D, Berkowitz R. Changes in clinical presentation of postterm choriocarcinoma at the New England Trophoblastic Disease Center in recent years. Gynecol Oncol. 2013 Sep; 130(3):483-6.
    View in: PubMed
  8. Viswanathan AN, Pinto AP, Schultz D, Berkowitz R, Crum CP. Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma. Gynecol Oncol. 2013 Sep; 130(3):545-9.
    View in: PubMed
  9. May T, Yang J, Shoni M, Liu S, He H, Gali R, Ng SK, Crum C, Berkowitz RS, Ng SW. BRCA1 Expression Is Epigenetically Repressed in Sporadic Ovarian Cancer Cells by Overexpression of C-Terminal Binding Protein 2. Neoplasia. 2013 Jun; 15(6):600-8.
    View in: PubMed
  10. Cohn DE, Leitao M, Levenback C, Berkowitz R, Roman L, Lucci J, Kim S, Lancaster J, Odunsi K, Wakabayashi M, Goff BA. Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: An early glimpse into a challenging initiative. Gynecol Oncol. 2013 Sep; 130(3):403-6.
    View in: PubMed
  11. Maestá I, Growdon WB, Goldstein DP, Bernstein MR, Horowitz NS, Rudge MV, Berkowitz RS. Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia. Gynecol Oncol. 2013 Aug; 130(2):312-6.
    View in: PubMed
  12. Worley MJ, Welch WR, Berkowitz RS, Ng SW. Endometriosis-associated ovarian cancer: a review of pathogenesis. Int J Mol Sci. 2013; 14(3):5367-79.
    View in: PubMed
  13. Worley MJ, Guseh SH, Rauh-Hain JA, Williams KA, Muto MG, Feltmate CM, Berkowitz RS, Horowitz NS. Does neoadjuvant chemotherapy decrease the risk of hospital readmission following debulking surgery? Gynecol Oncol. 2013 Apr; 129(1):69-73.
    View in: PubMed
  14. Rauh-Hain JA, Nitschmann CC, Worley MJ, Bradford LS, Berkowitz RS, Schorge JO, Campos SM, Del Carmen MG, Horowitz NS. Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma. Gynecol Oncol. 2013 Apr; 129(1):63-8.
    View in: PubMed
  15. Townamchai K, Berkowitz R, Bhagwat M, Damato AL, Friesen S, Lee LJ, Matulonis U, O'Farrell D, Viswanathan AN. Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer. Gynecol Oncol. 2013 Apr; 129(1):18-21.
    View in: PubMed
  16. McAuliffe SM, Morgan SL, Wyant GA, Tran LT, Muto KW, Chen YS, Chin KT, Partridge JC, Poole BB, Cheng KH, Daggett J, Cullen K, Kantoff E, Hasselbatt K, Berkowitz J, Muto MG, Berkowitz RS, Aster JC, Matulonis UA, Dinulescu DM. Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy. Proc Natl Acad Sci U S A. 2012 Oct 23; 109(43):E2939-48.
    View in: PubMed
  17. Wang ZC, Birkbak NJ, Culhane AC, Drapkin R, Fatima A, Tian R, Schwede M, Alsop K, Daniels KE, Piao H, Liu J, Etemadmoghadam D, Miron A, Salvesen HB, Mitchell G, DeFazio A, Quackenbush J, Berkowitz RS, Iglehart JD, Bowtell DD, Matulonis UA. Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcome. Clin Cancer Res. 2012 Oct 15; 18(20):5806-15.
    View in: PubMed
  18. Saw YT, Yang J, Ng SK, Liu S, Singh S, Singh M, Welch WR, Tsuda H, Fong WP, Thompson D, Vasiliou V, Berkowitz RS, Ng SW. Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere cultures. BMC Cancer. 2012; 12:329.
    View in: PubMed
  19. Cheung TH, Man KN, Yu MY, Yim SF, Siu NS, Lo KW, Doran G, Wong RR, Wang VW, Smith DI, Worley MJ, Berkowitz RS, Chung TK, Wong YF. Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm. Cell Cycle. 2012 Aug 1; 11(15):2876-84.
    View in: PubMed
  20. Berkowitz RS, Goldstein DP. Current advances in the management of gestational trophoblastic disease. Gynecol Oncol. 2013 Jan; 128(1):3-5.
    View in: PubMed
  21. Fülöp V, Szigetvári I, Szepesi J, Végh G, Singh M, Berkowitz RS. Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years. J Reprod Med. 2012 Jul-Aug; 57(7-8):310-8.
    View in: PubMed
  22. Dantas PR, Maestá I, Cortés-Charry R, Growdon WB, Braga A, Rudge MV, Berkowitz RS. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study. J Reprod Med. 2012 Jul-Aug; 57(7-8):305-9.
    View in: PubMed
  23. Rodriguez N, Yang J, Hasselblatt K, Liu S, Zhou Y, Rauh-Hain JA, Ng SK, Choi PW, Fong WP, Agar NY, Welch WR, Berkowitz RS, Ng SW. Casein kinase I epsilon interacts with mitochondrial proteins for the growth and survival of human ovarian cancer cells. EMBO Mol Med. 2012 Sep; 4(9):952-63.
    View in: PubMed
  24. Shah NT, Barroilhet L, Berkowitz RS, Goldstein DP, Horowitz N. A cost analysis of first-line chemotherapy for low-risk gestational trophoblastic neoplasia. J Reprod Med. 2012 May-Jun; 57(5-6):211-8.
    View in: PubMed
  25. Berkowitz RS. Gestational trophoblastic disease: Presentations from the XVIth World Congress on Gestational Trophoblastic Diseases. J Reprod Med. 2012 May-Jun; 57(5-6):187-8.
    View in: PubMed
  26. Braga A, Growdon WB, Bernstein M, Maestá I, Rudge MV, Goldstein DP, Berkowitz RS. Molar pregnancy in adolescents. J Reprod Med. 2012 May-Jun; 57(5-6):225-30.
    View in: PubMed
  27. Elias KM, Shoni M, Bernstein M, Goldstein DP, Berkowitz RS. Complete hydatidiform mole in women aged 40 to 49 years. J Reprod Med. 2012 May-Jun; 57(5-6):254-8.
    View in: PubMed
  28. Rauh-Hain JA, Growdon WB, Braga A, Goldstein DP, Berkowitz RS. Gestational trophoblastic neoplasia in adolescents. J Reprod Med. 2012 May-Jun; 57(5-6):237-42.
    View in: PubMed
  29. Singh M, Kindelberger D, Nagymanyoki Z, Ng SW, Quick CM, Yamamoto H, Fichorova R, Fulop V, Berkowitz RS. Vascular endothelial growth factors and their receptors and regulators in gestational trophoblastic diseases and normal placenta. J Reprod Med. 2012 May-Jun; 57(5-6):197-203.
    View in: PubMed
  30. Rauh-Hain JA, Winograd D, Growdon WB, Schorge JO, Goodman AK, Boruta DM, Berkowitz RS, Horowitz NS, Del Carmen MG. Prognostic determinants in patients with uterine and ovarian clear carcinoma. Gynecol Oncol. 2012 May; 125(2):376-80.
    View in: PubMed
  31. Rodriguez N, Rauh-Hain JA, Shoni M, Berkowitz RS, Muto MG, Feltmate C, Schorge JO, Del Carmen MG, Matulonis UA, Horowitz NS. Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy. Gynecol Oncol. 2012 May; 125(2):362-6.
    View in: PubMed
  32. Berkowitz RS. Gynecologic cancer. Hematol Oncol Clin North Am. 2012 Feb; 26(1):xi-xii.
    View in: PubMed
  33. Keskin DB, Reinhold B, Lee SY, Zhang G, Lank S, O'Connor DH, Berkowitz RS, Brusic V, Kim SJ, Reinherz EL. Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimens. Front Immunol. 2011; 2:75.
    View in: PubMed
  34. Goldstein DP, Berkowitz RS. Current management of gestational trophoblastic neoplasia. Hematol Oncol Clin North Am. 2012 Feb; 26(1):111-31.
    View in: PubMed
  35. Viswanathan AN, Macklin EA, Berkowitz R, Matulonis U. The importance of chemotherapy and radiation in uterine papillary serous carcinoma. Gynecol Oncol. 2011 Dec; 123(3):542-7.
    View in: PubMed
  36. May T, Goldstein DP, Berkowitz RS. Current chemotherapeutic management of patients with gestational trophoblastic neoplasia. Chemother Res Pract. 2011; 2011:806256.
    View in: PubMed
  37. Singh M, Kindelberger D, Nagymanyoki Z, Ng SW, Quick CM, Elias KM, Yamamoto H, Fichorova R, Fulop V, Berkowitz RS. Matrix metalloproteinases and their inhibitors and inducer in gestational trophoblastic diseases and normal placenta. Gynecol Oncol. 2011 Jul; 122(1):178-82.
    View in: PubMed
  38. May T, Rabinowe SN, Berkowitz RS, Goldstein DP. Cerebral venous sinus thrombosis presenting as cerebral metastasis in a patient with choriocarcinoma following a non-molar gestation. Gynecol Oncol. 2011 Jul; 122(1):199-200.
    View in: PubMed
  39. Young JL, Koon EC, Kwong J, Welch WR, Muto MG, Berkowitz RS, Mok SC. Differential hRad17 expression by histologic subtype of ovarian cancer. J Ovarian Res. 2011; 4(1):6.
    View in: PubMed
  40. Gao Z, Xu X, McClane B, Zeng Q, Litkouhi B, Welch WR, Berkowitz RS, Mok SC, Garner EI. C terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to Taxol and Carboplatin. Clin Cancer Res. 2011 Mar 1; 17(5):1065-74.
    View in: PubMed
  41. Rodriguez N, Goldstein DP, Berkowitz RS. Treating gestational trophoblastic disease. Expert Opin Pharmacother. 2010 Dec; 11(18):3027-39.
    View in: PubMed
  42. Cramer DW, Vitonis AF, Welch WR, Terry KL, Goodman A, Rueda BR, Berkowitz RS. Correlates of the preoperative level of CA125 at presentation of ovarian cancer. Gynecol Oncol. 2010 Dec; 119(3):462-8.
    View in: PubMed
  43. Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. Lancet. 2010 Aug 28; 376(9742):717-29.
    View in: PubMed
  44. Ghosh S, Albitar L, LeBaron R, Welch WR, Samimi G, Birrer MJ, Berkowitz RS, Mok SC. Up-regulation of stromal versican expression in advanced stage serous ovarian cancer. Gynecol Oncol. 2010 Oct; 119(1):114-20.
    View in: PubMed
  45. Growdon WB, Wolfberg AJ, Goldstein DP, Feltmate CM, Chinchilla ME, Lieberman ES, Berkowitz RS. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy. J Reprod Med. 2010 Jul-Aug; 55(7-8):279-84.
    View in: PubMed
  46. Folkins A, Cruz L, Goldstein DP, Berkowitz RS, Crum C, Kindelberger D. Utility of chromosomal chromogenic in situ hybridization as an alternative to flow cytometry and cytogenetics in the diagnosis of early partial hydatidiform moles: a validation study. J Reprod Med. 2010 Jul-Aug; 55(7-8):275-8.
    View in: PubMed
  47. Nagymanyoki Z, Kindelberger D, Clark R, Rodriguez N, Fulop V, Berkowitz RS. Age related cellular immune response against complete molar pregnancy. J Reprod Med. 2010 May-Jun; 55(5-6):261-6.
    View in: PubMed
  48. Clark RM, Nevadunsky NS, Ghosh S, Goldstein DP, Berkowitz RS. The evolving role of hysterectomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center. J Reprod Med. 2010 May-Jun; 55(5-6):194-8.
    View in: PubMed
  49. Berkowitz RS. Gestational trophoblastic disease. Presentations from the XVth World Congress on gestational trophoblastic diseases. J Reprod Med. 2010 May-Jun; 55(5-6):182-3.
    View in: PubMed
  50. Fülöp V, Szigetvári I, Szepesi J, Végh G, Bátorfi J, Nagymányoki Z, Török M, Berkowitz RS. 30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary. J Reprod Med. 2010 May-Jun; 55(5-6):253-7.
    View in: PubMed
  51. Elias KM, Goldstein DP, Berkowitz RS. Complete hydatidiform mole in women older than age 50. J Reprod Med. 2010 May-Jun; 55(5-6):208-12.
    View in: PubMed
  52. Seckl MJ, Savage PM, Hancock BW, Berkowitz RS, Goldstein DP, Lurain JR, Schink JC, Cagayan FM, Golfier F, Ngan H, Wake N, Osborne R, Sasaki S, Charry RC, Wong LC, Sekharan PK, Djamhoer MA, Massuger L, Belfort P, Kim SJ, Lee C, Jung SG. "Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases". Gynecol Oncol. 2010 Jun; 117(3):505-6; author reply 506-7.
    View in: PubMed
  53. Tang L, Yang J, Ng SK, Rodriguez N, Choi PW, Vitonis A, Wang K, McLachlan GJ, Caiazzo RJ, Liu BC, Welch WR, Cramer DW, Berkowitz RS, Ng SW. Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer. Eur J Cancer. 2010 Jan; 46(1):170-9.
    View in: PubMed
  54. Xian W, Miron A, Roh M, Semmel DR, Yassin Y, Garber J, Oliva E, Goodman A, Mehra K, Berkowitz RS, Crum CP, Quade BJ. The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube. J Pathol. 2010 Jan; 220(1):17-23.
    View in: PubMed
  55. Mok SC, Bonome T, Vathipadiekal V, Bell A, Johnson ME, Wong KK, Park DC, Hao K, Yip DK, Donninger H, Ozbun L, Samimi G, Brady J, Randonovich M, Pise-Masison CA, Barrett JC, Wong WH, Welch WR, Berkowitz RS, Birrer MJ. A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. Cancer Cell. 2009 Dec 8; 16(6):521-32.
    View in: PubMed
  56. Boyce EA, Costaggini I, Vitonis A, Feltmate C, Muto M, Berkowitz R, Cramer D, Horowitz NS. The epidemiology of ovarian granulosa cell tumors: a case-control study. Gynecol Oncol. 2009 Nov; 115(2):221-5.
    View in: PubMed
  57. Kwong J, Chan FL, Wong KK, Birrer MJ, Archibald KM, Balkwill FR, Berkowitz RS, Mok SC. Inflammatory cytokine tumor necrosis factor alpha confers precancerous phenotype in an organoid model of normal human ovarian surface epithelial cells. Neoplasia. 2009 Jun; 11(6):529-41.
    View in: PubMed
  58. Berkowitz RS, Goldstein DP. Clinical practice. Molar pregnancy. N Engl J Med. 2009 Apr 16; 360(16):1639-45.
    View in: PubMed
  59. Horowitz NS, Goldstein DP, Berkowitz RS. Management of gestational trophoblastic neoplasia. Semin Oncol. 2009 Apr; 36(2):181-9.
    View in: PubMed
  60. Growdon WB, Wolfberg AJ, Goldstein DP, Feltmate CM, Chinchilla ME, Lieberman ES, Berkowitz RS. Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia. Gynecol Oncol. 2009 Feb; 112(2):353-7.
    View in: PubMed
  61. Callahan MJ, Nagymanyoki Z, Bonome T, Johnson ME, Litkouhi B, Sullivan EH, Hirsch MS, Matulonis UA, Liu J, Birrer MJ, Berkowitz RS, Mok SC. Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer. Clin Cancer Res. 2008 Dec 1; 14(23):7667-73.
    View in: PubMed
  62. Nevadunsky NS, Barbieri JS, Kwong J, Merritt MA, Welch WR, Berkowitz RS, Mok SC. RUNX3 protein is overexpressed in human epithelial ovarian cancer. Gynecol Oncol. 2009 Feb; 112(2):325-30.
    View in: PubMed
  63. Ko EM, Muto MG, Berkowitz RS, Feltmate CM. Robotic versus open radical hysterectomy: a comparative study at a single institution. Gynecol Oncol. 2008 Dec; 111(3):425-30.
    View in: PubMed
  64. Berkowitz RS, Goldstein DP. Current management of gestational trophoblastic diseases. Gynecol Oncol. 2009 Mar; 112(3):654-62.
    View in: PubMed
  65. Nagymanyoki Z, Growdon WB, Sarno J, Callahan MJ, Parast MM, Fulop V, Mok SC, Horowitz N, Berkowitz RS. Vascularization and expression of angiogenic factors in partial and complete molar pregnancies. J Reprod Med. 2008 Aug; 53(8):589-94.
    View in: PubMed
  66. Nagymanyoki Z, Callahan MJ, Parast MM, Fulop V, Mok SC, Berkowitz RS. Immune cell profiling in intraplacental and postmolar choriocarcinomas. J Reprod Med. 2008 Aug; 53(8):558-64.
    View in: PubMed
  67. Berkowitz RS, Goldstein DP. Gestational trophoblastic disease: presentations from the XLVTH World Congress on Gestational Trophoblastic Diseases. J Reprod Med. 2008 Jul; 53(7):455-6.
    View in: PubMed
  68. Fleming EL, Garrett L, Growdon WB, Callahan M, Nevadunsky N, Ghosh S, Goldstein DP, Berkowitz RS. The changing role of thoracotomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center. J Reprod Med. 2008 Jul; 53(7):493-8.
    View in: PubMed
  69. Nagymanyoki Z, Butler MO, Callahan MJ, Parast MM, Fulop V, Mok SC, Berkowitz RS. Antigen-specific T cell immune response detected by skewed T cell receptor usage in normal placenta and complete molar pregnancy. J Reprod Med. 2008 Jul; 53(7):528-34.
    View in: PubMed
  70. Fülöp V, Szigetvri I, Szepesi J, Török M, Berkowitz RS. Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary. J Reprod Med. 2008 Jul; 53(7):541-6.
    View in: PubMed
  71. Garrett LA, Garner EI, Feltmate CM, Goldstein DP, Berkowitz RS. Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia. J Reprod Med. 2008 Jul; 53(7):481-6.
    View in: PubMed
  72. Medeiros F, Callahan MJ, Elvin JA, Dorfman DM, Berkowitz RS, Quade BJ. Intraplacental choriocarcinoma arising in a second trimester placenta with partial hydatidiform mole. Int J Gynecol Pathol. 2008 Apr; 27(2):247-51.
    View in: PubMed
  73. Hill SJ, Berkowitz R, Granter SR, Hirsch MS. Pagetoid lesions of the vulva: a collision between malignant melanoma and extramammary Paget disease. Int J Gynecol Pathol. 2008 Apr; 27(2):292-6.
    View in: PubMed
  74. Litkouhi B, Litkouhi B, Fleming E, Welch WR, Berkowitz RS, Birrer MJ, Mok SC. Overexpression of CEACAM6 in borderline and invasive mucinous ovarian neoplasms. Gynecol Oncol. 2008 May; 109(2):234-9.
    View in: PubMed
  75. Stany MP, Bonome T, Wamunyokoli F, Zorn K, Ozbun L, Park DC, Hao K, Boyd J, Sood AK, Gershenson DM, Berkowitz RS, Mok SC, Birrer MJ. Classification of ovarian cancer: a genomic analysis. Adv Exp Med Biol. 2008; 622:23-33.
    View in: PubMed
  76. Koon EC, Ma PC, Salgia R, Welch WR, Christensen JG, Berkowitz RS, Mok SC. Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasion. Int J Gynecol Cancer. 2008 Sep-Oct; 18(5):976-84.
    View in: PubMed
  77. Nagymanyoki Z, Callahan MJ, Parast MM, Berkowitz RS, Mok SC, Fulop V. Overexpression of laminin receptor 1 on decidual cells in partial and complete mole. Gynecol Oncol. 2008 Jan; 108(1):121-5.
    View in: PubMed
  78. Kornblith AB, Powell M, Regan MM, Bennett S, Krasner C, Moy B, Younger J, Goodman A, Berkowitz R, Winer E. Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psychooncology. 2007 Oct; 16(10):895-903.
    View in: PubMed
  79. Nagymanyoki Z, Callahan MJ, Parast MM, Fulop V, Mok SC, Berkowitz RS. Immune cell profiling in normal pregnancy, partial and complete molar pregnancy. Gynecol Oncol. 2007 Nov; 107(2):292-7.
    View in: PubMed
  80. Callahan MJ, Crum CP, Medeiros F, Kindelberger DW, Elvin JA, Garber JE, Feltmate CM, Berkowitz RS, Muto MG. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol. 2007 Sep 1; 25(25):3985-90.
    View in: PubMed
  81. Cramer DW, Welch WR, Berkowitz RS, Godleski JJ. Presence of talc in pelvic lymph nodes of a woman with ovarian cancer and long-term genital exposure to cosmetic talc. Obstet Gynecol. 2007 Aug; 110(2 Pt 2):498-501.
    View in: PubMed
  82. Birrer MJ, Johnson ME, Hao K, Wong KK, Park DC, Bell A, Welch WR, Berkowitz RS, Mok SC. Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas. J Clin Oncol. 2007 Jun 1; 25(16):2281-7.
    View in: PubMed
  83. Lee S, Garner EI, Welch WR, Berkowitz RS, Mok SC. Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma. Gynecol Oncol. 2007 Aug; 106(2):311-7.
    View in: PubMed
  84. Kornblith AB, Powell M, Regan MM, Bennett S, Krasner C, Moy B, Younger J, Goodman A, Berkowitz R, Winer E. Erratum: Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psychooncology. 2007 May 24; 16(10).
    View in: PubMed
  85. Rojas-Espaillat L, Houck KL, Hernandez E, Berkowitz RS. Fertility-sparing surgery for persistent gestational trophoblastic neoplasia in the myometrium: a case report. J Reprod Med. 2007 May; 52(5):431-4.
    View in: PubMed
  86. Litkouhi B, Kwong J, Lo CM, Smedley JG, McClane BA, Aponte M, Gao Z, Sarno JL, Hinners J, Welch WR, Berkowitz RS, Mok SC, Garner EI. Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin. Neoplasia. 2007 Apr; 9(4):304-14.
    View in: PubMed
  87. Garner EI, Goldstein DP, Feltmate CM, Berkowitz RS. Gestational trophoblastic disease. Clin Obstet Gynecol. 2007 Mar; 50(1):112-22.
    View in: PubMed
  88. Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, Callahan MJ, Garner EO, Gordon RW, Birch C, Berkowitz RS, Muto MG, Crum CP. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol. 2007 Feb; 31(2):161-9.
    View in: PubMed
  89. Lu Z, Chen TC, Zhang A, Persons KS, Kohn N, Berkowitz R, Martinello S, Holick MF. An evaluation of the vitamin D3 content in fish: Is the vitamin D content adequate to satisfy the dietary requirement for vitamin D? J Steroid Biochem Mol Biol. 2007 Mar; 103(3-5):642-4.
    View in: PubMed
  90. Mok SC, Kwong J, Welch WR, Samimi G, Ozbun L, Bonome T, Birrer MJ, Berkowitz RS, Wong KK. Etiology and pathogenesis of epithelial ovarian cancer. Dis Markers. 2007; 23(5-6):367-76.
    View in: PubMed
  91. Feltmate CM, Growdon WB, Wolfberg AJ, Goldstein DP, Genest DR, Chinchilla ME, Lieberman ES, Berkowitz RS. Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy. J Reprod Med. 2006 Nov; 51(11):902-6.
    View in: PubMed
  92. Growdon WB, Wolfberg AJ, Feltmate CM, Goldstein DP, Genest DR, Chinchilla ME, Berkowitz RS, Lieberman ES. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies. J Reprod Med. 2006 Nov; 51(11):871-4.
    View in: PubMed
  93. Szigetvári I, Szepesi J, Végh G, Bátorfi J, Arató G, Gáti I, Berkowitz RS, Fülöp V. 25 years' experience in the treatment of gestational trophoblastic neoplasia in Hungary. J Reprod Med. 2006 Oct; 51(10):841-8.
    View in: PubMed
  94. Nishimura S, Tsuda H, Ito K, Jobo T, Yaegashi N, Inoue T, Sudo T, Berkowitz RS, Mok SC. Differential expression of ABCF2 protein among different histologic types of epithelial ovarian cancer and in clear cell adenocarcinomas of different organs. Hum Pathol. 2007 Jan; 38(1):134-9.
    View in: PubMed
  95. Wolfberg AJ, Growdon WB, Feltmate CM, Goldstein DP, Genest DR, Chinchilla ME, Berkowitz RS, Lieberman ES. Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy. Obstet Gynecol. 2006 Aug; 108(2):393-6.
    View in: PubMed
  96. Littell RD, Hallonquist H, Matulonis U, Seiden MV, Berkowitz RS, Duska LR. Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma. Gynecol Oncol. 2006 Nov; 103(2):570-4.
    View in: PubMed
  97. Viswanathan AN, Lee H, Hanson E, Berkowitz RS, Crum CP. Influence of margin status and radiation on recurrence after radical hysterectomy in Stage IB cervical cancer. Int J Radiat Oncol Biol Phys. 2006 Aug 1; 65(5):1501-7.
    View in: PubMed
  98. Huang KC, Park DC, Ng SK, Lee JY, Ni X, Ng WC, Bandera CA, Welch WR, Berkowitz RS, Mok SC, Ng SW. Selenium binding protein 1 in ovarian cancer. Int J Cancer. 2006 May 15; 118(10):2433-40.
    View in: PubMed
  99. Cole LA, Khanlian SA, Muller CY, Giddings A, Kohorn E, Berkowitz R. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors. Gynecol Oncol. 2006 Aug; 102(2):160-4.
    View in: PubMed
  100. Kwong J, Lee JY, Wong KK, Zhou X, Wong DT, Lo KW, Welch WR, Berkowitz RS, Mok SC. Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer. Neoplasia. 2006 Apr; 8(4):268-78.
    View in: PubMed
  101. Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman E. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy. Obstet Gynecol. 2006 Mar; 107(3):743.
    View in: PubMed
  102. Wamunyokoli FW, Bonome T, Lee JY, Feltmate CM, Welch WR, Radonovich M, Pise-Masison C, Brady J, Hao K, Berkowitz RS, Mok S, Birrer MJ. Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance. Clin Cancer Res. 2006 Feb 1; 12(3 Pt 1):690-700.
    View in: PubMed
  103. Ye B, Skates S, Mok SC, Horick NK, Rosenberg HF, Vitonis A, Edwards D, Sluss P, Han WK, Berkowitz RS, Cramer DW. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine. Clin Cancer Res. 2006 Jan 15; 12(2):432-41.
    View in: PubMed
  104. Hashiguchi Y, Tsuda H, Bandera CA, Nishimura S, Inoue T, Kawamura N, Berkowitz RS, Mok SC. Comparison of osteopontin expression in endometrioid endometrial cancer and ovarian endometrioid cancer. Med Oncol. 2006; 23(2):205-12.
    View in: PubMed
  105. Hashiguchi Y, Tsuda H, Inoue T, Berkowitz RS, Mok SC. PTEN expression in clear cell adenocarcinoma of the ovary. Gynecol Oncol. 2006 Apr; 101(1):71-5.
    View in: PubMed
  106. Feltmate CM, Lee KR, Johnson M, Schorge JO, Wong KK, Hao K, Welch WR, Bell DA, Berkowitz RS, Mok SC. Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas. Clin Cancer Res. 2005 Nov 1; 11(21):7651-7.
    View in: PubMed
  107. Tsuda H, Ito YM, Ohashi Y, Wong KK, Hashiguchi Y, Welch WR, Berkowitz RS, Birrer MJ, Mok SC. Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarray analyses. Clin Cancer Res. 2005 Oct 1; 11(19 Pt 1):6880-8.
    View in: PubMed
  108. Garner EI, Feltmate CM, Goldstein DP, Berkowitz RS. The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey. Gynecol Oncol. 2005 Oct; 99(1):3-5.
    View in: PubMed
  109. Wang V, Li C, Lin M, Welch W, Bell D, Wong YF, Berkowitz R, Mok SC, Bandera CA. Ovarian cancer is a heterogeneous disease. Cancer Genet Cytogenet. 2005 Sep; 161(2):170-3.
    View in: PubMed
  110. Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman E. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy. Obstet Gynecol. 2005 Sep; 106(3):548-52.
    View in: PubMed
  111. Wenzel L, DeAlba I, Habbal R, Kluhsman BC, Fairclough D, Krebs LU, Anton-Culver H, Berkowitz R, Aziz N. Quality of life in long-term cervical cancer survivors. Gynecol Oncol. 2005 May; 97(2):310-7.
    View in: PubMed
  112. Cramer DW, Titus-Ernstoff L, McKolanis JR, Welch WR, Vitonis AF, Berkowitz RS, Finn OJ. Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1125-31.
    View in: PubMed
  113. Duska LR, Berkowitz R, Matulonis U, Muto M, Goodman A, McIntyre JF, Klein A, Atkinson T, Seiden MV, Campos S. A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer. Gynecol Oncol. 2005 Jan; 96(1):198-203.
    View in: PubMed
  114. Wenzel L, Dogan-Ates A, Habbal R, Berkowitz R, Goldstein DP, Bernstein M, Kluhsman BC, Osann K, Newlands E, Seckl MJ, Hancock B, Cella D. Defining and measuring reproductive concerns of female cancer survivors. J Natl Cancer Inst Monogr. 2005; (34):94-8.
    View in: PubMed
  115. Huddleston HG, Wong KK, Welch WR, Berkowitz RS, Mok SC. Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker. Gynecol Oncol. 2005 Jan; 96(1):77-83.
    View in: PubMed
  116. Goldstein DP, Garner EI, Feltmate CM, Berkowitz RS. The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease. Gynecol Oncol. 2004 Dec; 95(3):421-2.
    View in: PubMed
  117. Tsuda H, Birrer MJ, Ito YM, Ohashi Y, Lin M, Lee C, Wong WH, Rao PH, Lau CC, Berkowitz RS, Wong KK, Mok SC. Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform. Cancer Genet Cytogenet. 2004 Dec; 155(2):97-107.
    View in: PubMed
  118. Wolfberg AJ, Feltmate C, Goldstein DP, Berkowitz RS, Lieberman E. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy. Obstet Gynecol. 2004 Sep; 104(3):551-4.
    View in: PubMed
  119. Ni X, Zhang W, Huang KC, Wang Y, Ng SK, Mok SC, Berkowitz RS, Ng SW. Characterisation of human kallikrein 6/protease M expression in ovarian cancer. Br J Cancer. 2004 Aug 16; 91(4):725-31.
    View in: PubMed
  120. Wenzel L, Berkowitz RS, Habbal R, Newlands E, Hancock B, Goldstein DP, Seckl M, Bernstein M, Strickland S, Higgins J. Predictors of quality of life among long-term survivors of gestational trophoblastic disease. J Reprod Med. 2004 Aug; 49(8):589-94.
    View in: PubMed
  121. Thaker HM, Berlin A, Tycko B, Goldstein DP, Berkowitz RS, Castrillon DH, Genest DR. Immunohistochemistry for the imprinted gene product IPL/PHLDA2 for facilitating the differential diagnosis of complete hydatidiform mole. J Reprod Med. 2004 Aug; 49(8):630-6.
    View in: PubMed
  122. Gamer EI, Garrett A, Goldstein DP, Berkowitz RS. Significance of chest computed tomography findings in the evaluation and treatment of persistent gestational trophoblastic neoplasia. J Reprod Med. 2004 Jun; 49(6):411-4.
    View in: PubMed
  123. Fulop V, Mok SC, Berkowitz RS. Molecular biology of gestational trophoblastic neoplasia: a review. J Reprod Med. 2004 Jun; 49(6):415-22.
    View in: PubMed
  124. Penson RT, Seiden MV, Goodman A, Fuller AF, Berkowitz RS, Matulonis UA, Krasner C, Lee H, Atkinson T, Campos SM. Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignancies. Gynecol Oncol. 2004 Jun; 93(3):702-7.
    View in: PubMed
  125. Schorge JO, Drake RD, Lee H, Skates SJ, Rajanbabu R, Miller DS, Kim JH, Cramer DW, Berkowitz RS, Mok SC. Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer. Clin Cancer Res. 2004 May 15; 10(10):3474-8.
    View in: PubMed
  126. Tsuda H, Bandera CA, Birrer MJ, Hashiguchi Y, Berkowitz RS, Mok SC. Cyclin E amplification and overexpression in clear cell adenocarcinoma of the ovary. Oncology. 2004; 67(3-4):291-9.
    View in: PubMed
  127. Garner E, Goldstein DP, Berkowitz RS, Wenzel L. Psychosocial and reproductive outcomes of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol. 2003 Dec; 17(6):959-68.
    View in: PubMed
  128. Matulonis U, Campos S, Duska L, Fuller A, Berkowitz R, Gore S, Roche M, Colella T, Lee H, Seiden MV. A phase II trial of three sequential doublets for the treatment of advanced müllerian malignancies. Gynecol Oncol. 2003 Nov; 91(2):293-8.
    View in: PubMed
  129. Kim JH, Herlyn D, Wong KK, Park DC, Schorge JO, Lu KH, Skates SJ, Cramer DW, Berkowitz RS, Mok SC. Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer. Clin Cancer Res. 2003 Oct 15; 9(13):4782-91.
    View in: PubMed
  130. Corren J, Berkowitz R, Murray JJ, Prenner B. Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma. Int J Clin Pract. 2003 Sep; 57(7):567-72.
    View in: PubMed
  131. Campos SM, Matulonis UA, Penson RT, Lee H, Berkowitz RS, Duska LR, Fuller AF, Wilson KS, Puchalski TA, Supko JG, Seiden MV. Phase II study of liposomal doxorubicin and weekly paclitaxel for recurrent Müllerian tumors. Gynecol Oncol. 2003 Sep; 90(3):610-8.
    View in: PubMed
  132. Ye B, Cramer DW, Skates SJ, Gygi SP, Pratomo V, Fu L, Horick NK, Licklider LJ, Schorge JO, Berkowitz RS, Mok SC. Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. Clin Cancer Res. 2003 Aug 1; 9(8):2904-11.
    View in: PubMed
  133. Feltmate CM, Batorfi J, Fulop V, Goldstein DP, Doszpod J, Berkowitz RS. Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation. Obstet Gynecol. 2003 Apr; 101(4):732-6.
    View in: PubMed
  134. Batorfi J, Fulop V, Kim JH, Genest DR, Doszpod J, Mok SC, Berkowitz RS. Osteopontin is down-regulated in hydatidiform mole. Gynecol Oncol. 2003 Apr; 89(1):134-9.
    View in: PubMed
  135. Batorfi J, Ye B, Mok SC, Cseh I, Berkowitz RS, Fulop V. Protein profiling of complete mole and normal placenta using ProteinChip analysis on laser capture microdissected cells. Gynecol Oncol. 2003 Mar; 88(3):424-8.
    View in: PubMed
  136. Garner EI, Meyerovitz M, Goldstein DP, Berkowitz RS. Successful term pregnancy after selective arterial embolization of symptomatic arteriovenous malformation in the setting of gestational trophoblastic tumor. Gynecol Oncol. 2003 Jan; 88(1):69-72.
    View in: PubMed
  137. Huang KC, Rao PH, Lau CC, Heard E, Ng SK, Brown C, Mok SC, Berkowitz RS, Ng SW. Relationship of XIST expression and responses of ovarian cancer to chemotherapy. Mol Cancer Ther. 2002 Aug; 1(10):769-76.
    View in: PubMed
  138. Crum CP, Berkowitz RS. Human papillomaviruses. Applications, caveats and prevention. J Reprod Med. 2002 Jul; 47(7):519-28; discussion 528-9.
    View in: PubMed
  139. Garner EI, Stokes EE, Berkowitz RS, Mok SC, Cramer DW. Polymorphisms of the estrogen-metabolizing genes CYP17 and catechol-O-methyltransferase and risk of epithelial ovarian cancer. Cancer Res. 2002 Jun 1; 62(11):3058-62.
    View in: PubMed
  140. Garner EI, Lipson E, Bernstein MR, Goldstein DP, Berkowitz RS. Subsequent pregnancy experience in patients with molar pregnancy and gestational trophoblastic tumor. J Reprod Med. 2002 May; 47(5):380-6.
    View in: PubMed
  141. Fulop V, Mok SC, Gati I, Berkowitz RS. Recent advances in molecular biology of gestational trophoblastic diseases. A review. J Reprod Med. 2002 May; 47(5):369-79.
    View in: PubMed
  142. Wenzel L, Berkowitz RS, Newlands E, Hancock B, Goldstein DP, Seckl MJ, Habbal R, Bernstein M, Kluhsman B, Kulchak-Rahm A, Strickland S, Higgins J. Quality of life after gestational trophoblastic disease. J Reprod Med. 2002 May; 47(5):387-94.
    View in: PubMed
  143. Berkowitz RS, Goldstein DP. Recent advances in the management of gestational trophoblastic disease: a symposium. J Reprod Med. 2002 May; 47(5):335-6.
    View in: PubMed
  144. Feltmate CM, Genest DR, Goldstein DP, Berkowitz RS. Advances in the understanding of placental site trophoblastic tumor. J Reprod Med. 2002 May; 47(5):337-41.
    View in: PubMed
  145. Genest DR, Ruiz RE, Weremowicz S, Berkowitz RS, Goldstein DP, Dorfman DM. Do nontriploid partial hydatidiform moles exist? A histologic and flow cytometric reevaluation of nontriploid specimens. J Reprod Med. 2002 May; 47(5):363-8.
    View in: PubMed
  146. Garrett AP, Garner EO, Goldstein DP, Berkowitz RS. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience. J Reprod Med. 2002 May; 47(5):355-62.
    View in: PubMed
  147. Kim JH, Skates SJ, Uede T, Wong KK, Schorge JO, Feltmate CM, Berkowitz RS, Cramer DW, Mok SC. Osteopontin as a potential diagnostic biomarker for ovarian cancer. JAMA. 2002 Apr 3; 287(13):1671-9.
    View in: PubMed
  148. Irvin WP, Rice LW, Berkowitz RS. Advances in the management of endometrial adenocarcinoma. A review. J Reprod Med. 2002 Mar; 47(3):173-89; discussion 189-90.
    View in: PubMed
  149. Mok SC, Chao J, Skates S, Wong K, Yiu GK, Muto MG, Berkowitz RS, Cramer DW. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology. J Natl Cancer Inst. 2001 Oct 3; 93(19):1458-64.
    View in: PubMed
  150. Ortiz BH, Ailawadi M, Colitti C, Muto MG, Deavers M, Silva EG, Berkowitz RS, Mok SC, Gershenson DM. Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors. Cancer Res. 2001 Oct 1; 61(19):7264-7.
    View in: PubMed
  151. Penson RT, Supko JG, Seiden MV, Fuller AF, Berkowitz RS, Goodman A, Campos SM, MacNeill KM, Cook S, Matulonis UA. A Phase I-II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent Müllerian tumors. Cancer. 2001 Sep 1; 92(5):1156-67.
    View in: PubMed
  152. Feltmate CM, Genest DR, Wise L, Bernstein MR, Goldstein DP, Berkowitz RS. Placental site trophoblastic tumor: a 17-year experience at the New England Trophoblastic Disease Center. Gynecol Oncol. 2001 Sep; 82(3):415-9.
    View in: PubMed
  153. Yiu GK, Chan WY, Ng SW, Chan PS, Cheung KK, Berkowitz RS, Mok SC. SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells. Am J Pathol. 2001 Aug; 159(2):609-22.
    View in: PubMed
  154. Garrett AP, Lee KR, Colitti CR, Muto MG, Berkowitz RS, Mok SC. k-ras mutation may be an early event in mucinous ovarian tumorigenesis. Int J Gynecol Pathol. 2001 Jul; 20(3):244-51.
    View in: PubMed
  155. Wang VW, Bell DA, Berkowitz RS, Mok SC. Whole genome amplification and high-throughput allelotyping identified five distinct deletion regions on chromosomes 5 and 6 in microdissected early-stage ovarian tumors. Cancer Res. 2001 May 15; 61(10):4169-74.
    View in: PubMed
  156. Campos SM, Penson RT, Mays AR, Berkowitz RS, Fuller AF, Goodman A, Matulonis UA, Muzikansky A, Seiden MV. The clinical utility of liposomal doxorubicin in recurrent ovarian cancer. Gynecol Oncol. 2001 May; 81(2):206-12.
    View in: PubMed
  157. Berkowitz RS, Tuncer ZS, Bernstein MR, Goldstein DP. Management of gestational trophoblastic diseases: subsequent pregnancy experience. Semin Oncol. 2000 Dec; 27(6):678-85.
    View in: PubMed
  158. Schorge JO, Goldstein DP, Bernstein MR, Berkowitz RS. Recent advances in gestational trophoblastic disease. J Reprod Med. 2000 Sep; 45(9):692-700.
    View in: PubMed
  159. Berkowitz RS. Recent advances in the understanding of reproductive malignancies. A new section. J Reprod Med. 2000 Sep; 45(9):691.
    View in: PubMed
  160. Benson CB, Genest DR, Bernstein MR, Soto-Wright V, Goldstein DP, Berkowitz RS. Sonographic appearance of first trimester complete hydatidiform moles. Ultrasound Obstet Gynecol. 2000 Aug; 16(2):188-91.
    View in: PubMed
  161. Huang LW, Garrett AP, Schorge JO, Muto MG, Bell DA, Welch WR, Berkowitz RS, Mok SC. Distinct allelic loss patterns in papillary serous carcinoma of the peritoneum. Am J Clin Pathol. 2000 Jul; 114(1):93-9.
    View in: PubMed
  162. Lu KH, Garber JE, Cramer DW, Welch WR, Niloff J, Schrag D, Berkowitz RS, Muto MG. Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy. J Clin Oncol. 2000 Jul; 18(14):2728-32.
    View in: PubMed
  163. Schorge JO, Goldstein DP, Bernstein MR, Berkowitz RS. Gestational trophoblastic disease. Curr Treat Options Oncol. 2000 Jun; 1(2):169-75.
    View in: PubMed
  164. Katz SD, Maskin C, Jondeau G, Cocke T, Berkowitz R, LeJemtel T. Near-maximal fractional oxygen extraction by active skeletal muscle in patients with chronic heart failure. J Appl Physiol. 2000 Jun; 88(6):2138-42.
    View in: PubMed
  165. Huang LW, Garrett AP, Bell DA, Welch WR, Berkowitz RS, Mok SC. Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors. Gynecol Oncol. 2000 Jun; 77(3):369-76.
    View in: PubMed
  166. Tuncer ZS, Vegh GL, Fulop V, Genest DR, Mok SC, Berkowitz RS. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor. Gynecol Oncol. 2000 Jun; 77(3):389-93.
    View in: PubMed
  167. Tung N, Berkowitz R, Matulonis U, Quartulli M, Seiden M, Kim Y, Niloff J, Cannistra SA. Phase I trial of carboplatin, paclitaxel, etoposide, and cyclophosphamide with granulocyte colony stimulating factor as first-line therapy for patients with advanced epithelial ovarian cancer. Gynecol Oncol. 2000 May; 77(2):271-7.
    View in: PubMed
  168. Ng SW, Yiu GK, Liu Y, Huang LW, Palnati M, Jun SH, Berkowitz RS, Mok SC. Analysis of p73 in human borderline and invasive ovarian tumor. Oncogene. 2000 Apr 6; 19(15):1885-90.
    View in: PubMed
  169. Garrett AP, Ng SW, Muto MG, Welch WR, Bell DA, Berkowitz RS, Mok SC. ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum. Gynecol Oncol. 2000 Apr; 77(1):105-11.
    View in: PubMed
  170. Schorge JO, Muto MG, Lee SJ, Huang LW, Welch WR, Bell DA, Keung EZ, Berkowitz RS, Mok SC. BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis. Cancer Res. 2000 Mar 1; 60(5):1361-4.
    View in: PubMed
  171. Schorge JO, Miller YB, Qi LJ, Muto MG, Welch WR, Berkowitz RS, Mok SC. Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum. Gynecol Oncol. 2000 Mar; 76(3):369-72.
    View in: PubMed
  172. Huang LW, Garrett AP, Muto MG, Colitti CV, Bell DA, Welch WR, Berkowitz RS, Mok SC. Identification of a novel 9 cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum. Hum Pathol. 2000 Mar; 31(3):367-73.
    View in: PubMed
  173. Chan WY, Cheung KK, Schorge JO, Huang LW, Welch WR, Bell DA, Berkowitz RS, Mok SC. Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. Am J Pathol. 2000 Feb; 156(2):409-17.
    View in: PubMed
  174. Bakri Y, al-Hawashim N, Berkowitz R. CSF/serum beta-hCG ratio in patients with brain metastases of gestational trophoblastic tumor. J Reprod Med. 2000 Feb; 45(2):94-6.
    View in: PubMed
  175. Vegh GL, Fulop V, Liu Y, Ng SW, Tuncer ZS, Genest DR, Paldi-Haris P, Foldi J, Mok SC, Berkowitz RS. Differential gene expression pattern between normal human trophoblast and choriocarcinoma cell lines: downregulation of heat shock protein-27 in choriocarcinoma in vitro and in vivo. Gynecol Oncol. 1999 Dec; 75(3):391-6.
    View in: PubMed
  176. Vegh GL, Selcuk Tuncer Z, Fulop V, Genest DR, Mok SC, Berkowitz RS. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta. Gynecol Oncol. 1999 Nov; 75(2):248-53.
    View in: PubMed
  177. Tuncer ZS, Bernstein MR, Wang J, Goldstein DP, Berkowitz RS. Repetitive hydatidiform mole with different male partners. Gynecol Oncol. 1999 Nov; 75(2):224-6.
    View in: PubMed
  178. Garner EI, Chang-Lee WY, Lu KH, Goldstein DP, Berkowitz RS. Trophoblastic pulmonary embolization after hysterectomy for invasive complete mole. A case report. J Reprod Med. 1999 Oct; 44(10):908-12.
    View in: PubMed
  179. Tuncer ZS, Bernstein MR, Goldstein DP, Lu KH, Berkowitz RS. Outcome of pregnancies occurring within 1 year of hydatidiform mole. Obstet Gynecol. 1999 Oct; 94(4):588-90.
    View in: PubMed
  180. Tuncer ZS, Bernstein MR, Goldstein DP, Berkowitz RS. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor. Gynecol Oncol. 1999 Jun; 73(3):345-7.
    View in: PubMed
  181. Kim HK, Silver B, Berkowitz R, Howes A. Bulky, barrel-shaped cervical carcinoma (stages IB, IIA, IIB): the prognostic factors for pelvic control and treatment outcome. Am J Clin Oncol. 1999 Jun; 22(3):232-6.
    View in: PubMed
  182. Palmer JR, Driscoll SG, Rosenberg L, Berkowitz RS, Lurain JR, Soper J, Twiggs LB, Gershenson DM, Kohorn EI, Berman M, Shapiro S, Rao RS. Oral contraceptive use and risk of gestational trophoblastic tumors. J Natl Cancer Inst. 1999 Apr 7; 91(7):635-40.
    View in: PubMed
  183. Ng SW, Liu Y, Hasselblatt KT, Mok SC, Berkowitz RS. A new human topoisomerase III that interacts with SGS1 protein. Nucleic Acids Res. 1999 Feb 15; 27(4):993-1000.
    View in: PubMed
  184. Iyengar TD, Ng S, Lau CC, Welch WR, Bell DA, Berkowitz RS, Mok SC. Differential expression of NF1 type I and type II isoforms in sporadic borderline and invasive epithelial ovarian tumors. Oncogene. 1999 Jan 7; 18(1):257-62.
    View in: PubMed
  185. Bandera CA, Muto MG, Schorge JO, Berkowitz RS, Rubin SC, Mok SC. BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum. Obstet Gynecol. 1998 Oct; 92(4 Pt 1):596-600.
    View in: PubMed
  186. Mirhashemi R, Harlow BL, Ginsburg ES, Signorello LB, Berkowitz R, Feldman S. Predicting risk of complications with gynecologic laparoscopic surgery. Obstet Gynecol. 1998 Sep; 92(3):327-31.
    View in: PubMed
  187. Fulop V, Colitti CV, Genest D, Berkowitz RS, Yiu GK, Ng SW, Szepesi J, Mok SC. DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases. Oncogene. 1998 Jul 30; 17(4):419-24.
    View in: PubMed
  188. Bandera CA, Muto MG, Welch WR, Berkowitz RS, Mok SC. Genetic imbalance on chromosome 17 in papillary serous carcinoma of the peritoneum. Oncogene. 1998 Jul 2; 16(26):3455-9.
    View in: PubMed
  189. Schorge JO, Muto MG, Welch WR, Bandera CA, Rubin SC, Bell DA, Berkowitz RS, Mok SC. Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. J Natl Cancer Inst. 1998 Jun 3; 90(11):841-5.
    View in: PubMed
  190. Lu KH, Bell DA, Welch WR, Berkowitz RS, Mok SC. Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors. Cancer Res. 1998 Jun 1; 58(11):2328-30.
    View in: PubMed
  191. Mok SC, Chan WY, Wong KK, Cheung KK, Lau CC, Ng SW, Baldini A, Colitti CV, Rock CO, Berkowitz RS. DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer. Oncogene. 1998 May 7; 16(18):2381-7.
    View in: PubMed
  192. Fulop V, Mok SC, Genest DR, Szigetvari I, Cseh I, Berkowitz RS. c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. J Reprod Med. 1998 Feb; 43(2):101-10.
    View in: PubMed
  193. Berkowitz RS, Goldstein DP. Recent advances in gestational trophoblastic disease. Curr Opin Obstet Gynecol. 1998 Feb; 10(1):61-4.
    View in: PubMed
  194. Bunnell CA, Thompson L, Buswell L, Berkowitz R, Muto M, Sheets E, Shulman LN. A Phase I trial of ifosfamide and paclitaxel with granulocyte-colony stimulating factor in the treatment of patients with refractory solid tumors. Cancer. 1998 Feb 1; 82(3):561-6.
    View in: PubMed
  195. Fulop V, Mok SC, Genest DR, Gati I, Doszpod J, Berkowitz RS. p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. J Reprod Med. 1998 Feb; 43(2):119-27.
    View in: PubMed
  196. Colitti CV, Rodabaugh KJ, Welch WR, Berkowitz RS, Mok SC. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas. Oncogene. 1998 Jan 29; 16(4):555-9.
    View in: PubMed
  197. Edelson MI, Lau CC, Colitti CV, Welch WR, Bell DA, Berkowitz RS, Mok SC. A one centimorgan deletion unit on chromosome Xq12 is commonly lost in borderline and invasive epithelial ovarian tumors. Oncogene. 1998 Jan 15; 16(2):197-202.
    View in: PubMed
  198. Mosher R, Goldstein DP, Berkowitz R, Bernstein M, Genest DR. Complete hydatidiform mole. Comparison of clinicopathologic features, current and past. J Reprod Med. 1998 Jan; 43(1):21-7.
    View in: PubMed
  199. Berkowitz RS, Im SS, Bernstein MR, Goldstein DP. Gestational trophoblastic disease. Subsequent pregnancy outcome, including repeat molar pregnancy. J Reprod Med. 1998 Jan; 43(1):81-6.
    View in: PubMed
  200. Felemban AA, Bakri YN, Alkharif HA, Altuwaijri SM, Shalhoub J, Berkowitz RS. Complete molar pregnancy. Clinical trends at King Fahad Hospital, Riyadh, Kingdom of Saudi Arabia. J Reprod Med. 1998 Jan; 43(1):11-3.
    View in: PubMed
  201. Keefe KA, Wald JS, Goldstein DP, Bernstein M, Berkowitz RS. Reproductive outcome after methotrexate treatment of tubal pregnancies. J Reprod Med. 1998 Jan; 43(1):28-32.
    View in: PubMed
  202. Goldstein DP, Zanten-Przybysz IV, Bernstein MR, Berkowitz RS. Revised FIGO staging system for gestational trophoblastic tumors. Recommendations regarding therapy. J Reprod Med. 1998 Jan; 43(1):37-43.
    View in: PubMed
  203. Rodabaugh KJ, Bernstein MR, Goldstein DP, Berkowitz RS. Natural history of postterm choriocarcinoma. J Reprod Med. 1998 Jan; 43(1):75-80.
    View in: PubMed
  204. Edelson MI, Scherer SW, Tsui LC, Welch WR, Bell DA, Berkowitz RS, Mok SC. Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas. Oncogene. 1997 Jun 19; 14(24):2979-84.
    View in: PubMed
  205. Anderson LL, Lau CC, Gracely EJ, Berkowitz RS, Kassis AI. Enhancement of 131I-mediated cytotoxicity by caffeine. Gynecol Oncol. 1997 May; 65(2):253-7.
    View in: PubMed
  206. Lu KH, Weitzel JN, Kodali S, Welch WR, Berkowitz RS, Mok SC. A novel 4-cM minimally deleted region on chromosome 11p15.1 associated with high grade nonmucinous epithelial ovarian carcinomas. Cancer Res. 1997 Feb 1; 57(3):387-90.
    View in: PubMed
  207. Soto-Wright V, Goldstein DP, Bernstein MR, Berkowitz RS. The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D. Gynecol Oncol. 1997 Jan; 64(1):156-9.
    View in: PubMed
  208. Berkowitz RS, Goldstein DP. The diagnosis of molar pregnancy by ultrasound: a continuing challenge. Ultrasound Obstet Gynecol. 1997 Jan; 9(1):4-5.
    View in: PubMed
  209. Berkowitz RS, Goldstein DP. Chorionic tumors. N Engl J Med. 1996 Dec 5; 335(23):1740-8.
    View in: PubMed
  210. Stunkard A, Berkowitz R, Tanrikut C, Reiss E, Young L. d-fenfluramine treatment of binge eating disorder. Am J Psychiatry. 1996 Nov; 153(11):1455-9.
    View in: PubMed
  211. Tangir J, Loughridge NS, Berkowitz RS, Muto MG, Bell DA, Welch WR, Mok SC. Frequent microsatellite instability in epithelial borderline ovarian tumors. Cancer Res. 1996 Jun 1; 56(11):2501-5.
    View in: PubMed
  212. Wertheim I, Tangir J, Muto MG, Welch WR, Berkowitz RS, Chen WY, Mok SC. Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors. Oncogene. 1996 May 16; 12(10):2147-53.
    View in: PubMed
  213. Mok SC, Chan WY, Wong KK, Muto MG, Berkowitz RS. SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells. Oncogene. 1996 May 2; 12(9):1895-901.
    View in: PubMed
  214. Montes M, Roberts D, Berkowitz RS, Genest DR. Prevalence and significance of implantation site trophoblastic atypia in hydatidiform moles and spontaneous abortions. Am J Clin Pathol. 1996 Apr; 105(4):411-6.
    View in: PubMed
  215. Muto MG, Cramer DW, Tangir J, Berkowitz R, Mok S. Frequency of the BRCA1 185delAG mutation among Jewish women with ovarian cancer and matched population controls. Cancer Res. 1996 Mar 15; 56(6):1250-2.
    View in: PubMed
  216. Tangir J, Muto MG, Berkowitz RS, Welch WR, Bell DA, Mok SC. A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer. Oncogene. 1996 Feb 15; 12(4):735-40.
    View in: PubMed
  217. Berkowitz RS, Goldstein DP. Gestational trophoblastic disease. Cancer. 1995 Nov 15; 76(10 Suppl):2079-85.
    View in: PubMed
  218. Choi-Hong SR, Genest DR, Crum CP, Berkowitz R, Goldstein DP, Schofield DE. Twin pregnancies with complete hydatidiform mole and coexisting fetus: use of fluorescent in situ hybridization to evaluate placental X- and Y-chromosomal content. Hum Pathol. 1995 Nov; 26(11):1175-80.
    View in: PubMed
  219. Soto-Wright V, Bernstein M, Goldstein DP, Berkowitz RS. The changing clinical presentation of complete molar pregnancy. Obstet Gynecol. 1995 Nov; 86(5):775-9.
    View in: PubMed
  220. Rodabaugh KJ, Biggs RB, Qureshi JA, Barrett AJ, Welch WR, Bell DA, Berkowitz RS, Mok SC. Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors. Oncogene. 1995 Oct 5; 11(7):1249-54.
    View in: PubMed
  221. Rice LW, Mark SD, Berkowitz RS, Goff BA, Lage JM. Clinicopathologic variables, operative characteristics, and DNA ploidy in predicting outcome in ovarian epithelial carcinoma. Obstet Gynecol. 1995 Sep; 86(3):379-85.
    View in: PubMed
  222. Berkowitz RS, Bernstein MR, Harlow BL, Rice LW, Lage JM, Goldstein DP, Cramer DW. Case-control study of risk factors for partial molar pregnancy. Am J Obstet Gynecol. 1995 Sep; 173(3 Pt 1):788-94.
    View in: PubMed
  223. Tsao SW, Mok SC, Fey EG, Fletcher JA, Wan TS, Chew EC, Muto MG, Knapp RC, Berkowitz RS. Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs). Exp Cell Res. 1995 Jun; 218(2):499-507.
    View in: PubMed
  224. Mok SC, Kwok TT, Berkowitz RS, Barrett AJ, Tsui FW. Overexpression of the protein tyrosine phosphatase, nonreceptor type 6 (PTPN6), in human epithelial ovarian cancer. Gynecol Oncol. 1995 Jun; 57(3):299-303.
    View in: PubMed
  225. Rodabaugh KJ, Blanchard G, Welch WR, Bell DA, Berkowitz RS, Mok SC. Detailed deletion mapping of chromosome 6q in borderline epithelial ovarian tumors. Cancer Res. 1995 May 15; 55(10):2169-72.
    View in: PubMed
  226. Feldman S, Goldstein DP, Berkowitz RS. Low-risk metastatic gestational trophoblastic tumors. Semin Oncol. 1995 Apr; 22(2):166-71.
    View in: PubMed
  227. Goldstein DP, Berkowitz RS. Prophylactic chemotherapy of complete molar pregnancy. Semin Oncol. 1995 Apr; 22(2):157-60.
    View in: PubMed
  228. Feldman S, Cook EF, Harlow BL, Berkowitz RS. Predicting endometrial cancer among older women who present with abnormal vaginal bleeding. Gynecol Oncol. 1995 Mar; 56(3):376-81.
    View in: PubMed
  229. Muto MG, Welch WR, Mok SC, Bandera CA, Fishbaugh PM, Tsao SW, Lau CC, Goodman HM, Knapp RC, Berkowitz RS. Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. Cancer Res. 1995 Feb 1; 55(3):490-2.
    View in: PubMed
  230. van der Kolk BA, Dreyfuss D, Michaels M, Shera D, Berkowitz R, Fisler R, Saxe G. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry. 1994 Dec; 55(12):517-22.
    View in: PubMed
  231. Wertheim I, Muto MG, Welch WR, Bell DA, Berkowitz RS, Mok SC. p53 gene mutation in human borderline epithelial ovarian tumors. J Natl Cancer Inst. 1994 Oct 19; 86(20):1549-51.
    View in: PubMed
  232. Feldman S, Shapter A, Welch WR, Berkowitz RS. Two-year follow-up of 263 patients with post/perimenopausal vaginal bleeding and negative initial biopsy. Gynecol Oncol. 1994 Oct; 55(1):56-9.
    View in: PubMed
  233. Schatz F, Papp C, Toth-Pal E, Aigner S, Hausknecht V, Krikun G, Gordon RE, Berkowitz R, Lockwood CJ. In vitro regulation of stromelysin-1 in human endometrial stromal cells. Ann N Y Acad Sci. 1994 Sep 6; 732:479-81.
    View in: PubMed
  234. Saxe GN, Chinman G, Berkowitz R, Hall K, Lieberg G, Schwartz J, van der Kolk BA. Somatization in patients with dissociative disorders. Am J Psychiatry. 1994 Sep; 151(9):1329-34.
    View in: PubMed
  235. Wertheim I, Fleischhacker D, McLachlin CM, Rice LW, Berkowitz RS, Goff BA. Pseudomyxoma peritonei: a review of 23 cases. Obstet Gynecol. 1994 Jul; 84(1):17-21.
    View in: PubMed
  236. Shulman LN, Buswell L, Goodman H, Muto M, Berkowitz R, Teicher B, Kusumoto T, Hurwitz SJ, Kalish LA, Coleman CN. Phase I pharmacokinetic study of the hypoxic cell sensitizer etanidazole with carboplatin and cyclophosphamide in the treatment of advanced ovarian cancer. Int J Radiat Oncol Biol Phys. 1994 Jun 15; 29(3):545-8.
    View in: PubMed
  237. Tate JE, Mutter GL, Prasad CJ, Berkowitz R, Goodman H, Crum CP. Analysis of HPV-positive and -negative vulvar carcinomas for alterations in c-myc, Ha-, Ki-, and N-ras genes. Gynecol Oncol. 1994 Apr; 53(1):78-83.
    View in: PubMed
  238. Steller MA, Mok SC, Yeh J, Fulop V, Anderson DJ, Berkowitz RS. Effects of cytokines on epidermal growth factor receptor expression by malignant trophoblast cells in vitro. J Reprod Med. 1994 Mar; 39(3):209-16.
    View in: PubMed
  239. Bakri YN, Berkowitz RS, Khan J, Goldstein DP, von Sinner W, Jabbar FA. Pulmonary metastases of gestational trophoblastic tumor. Risk factors for early respiratory failure. J Reprod Med. 1994 Mar; 39(3):175-8.
    View in: PubMed
  240. Goldstein DP, Berkowitz RS. Current management of complete and partial molar pregnancy. J Reprod Med. 1994 Mar; 39(3):139-46.
    View in: PubMed
  241. Steller MA, Genest DR, Bernstein MR, Lage JM, Goldstein DP, Berkowitz RS. Clinical features of multiple conception with partial or complete molar pregnancy and coexisting fetuses. J Reprod Med. 1994 Mar; 39(3):147-54.
    View in: PubMed
  242. Berkowitz RS, Bernstein MR, Laborde O, Goldstein DP. Subsequent pregnancy experience in patients with gestational trophoblastic disease. New England Trophoblastic Disease Center, 1965-1992. J Reprod Med. 1994 Mar; 39(3):228-32.
    View in: PubMed
  243. Wenzel LB, Berkowitz RS, Robinson S, Goldstein DP, Bernstein MR. Psychological, social and sexual effects of gestational trophoblastic disease on patients and their partners. J Reprod Med. 1994 Mar; 39(3):163-7.
    View in: PubMed
  244. Feinberg BB, Anderson DJ, Steller MA, Fulop V, Berkowitz RS, Hill JA. Cytokine regulation of trophoblast steroidogenesis. J Clin Endocrinol Metab. 1994 Mar; 78(3):586-91.
    View in: PubMed
  245. Bakri Y, Berkowitz RS, Goldstein DP, Subhi J, Senoussi M, von Sinner W, Jabbar FA. Brain metastases of gestational trophoblastic tumor. J Reprod Med. 1994 Mar; 39(3):179-84.
    View in: PubMed
  246. Mok SC, Wong KK, Chan RK, Lau CC, Tsao SW, Knapp RC, Berkowitz RS. Molecular cloning of differentially expressed genes in human epithelial ovarian cancer. Gynecol Oncol. 1994 Feb; 52(2):247-52.
    View in: PubMed
  247. Steller MA, Genest DR, Bernstein MR, Lage JM, Goldstein DP, Berkowitz RS. Natural history of twin pregnancy with complete hydatidiform mole and coexisting fetus. Obstet Gynecol. 1994 Jan; 83(1):35-42.
    View in: PubMed
  248. Yanushpolsky EH, Ozturk M, Polgar K, Berkowitz RS, Hill JA. The effects of cytokines on human chorionic gonadotropin (hCG) production by a trophoblast cell line. J Reprod Immunol. 1993 Dec; 25(3):235-47.
    View in: PubMed
  249. Muto MG, Cramer DW, Brown DL, Welch WR, Harlow BL, Xu H, Brucks JP, Tsao SW, Berkowitz RS. Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center. Gynecol Oncol. 1993 Oct; 51(1):12-20.
    View in: PubMed
  250. Saxe GN, van der Kolk BA, Berkowitz R, Chinman G, Hall K, Lieberg G, Schwartz J. Dissociative disorders in psychiatric inpatients. Am J Psychiatry. 1993 Jul; 150(7):1037-42.
    View in: PubMed
  251. Feldman S, Berkowitz RS, Tosteson AN. Cost-effectiveness of strategies to evaluate postmenopausal bleeding. Obstet Gynecol. 1993 Jun; 81(6):968-75.
    View in: PubMed
  252. Mutter GL, Pomponio RJ, Berkowitz RS, Genest DR. Sex chromosome composition of complete hydatidiform moles: relationship to metastasis. Am J Obstet Gynecol. 1993 May; 168(5):1547-51.
    View in: PubMed
  253. Mok SC, Bell DA, Knapp RC, Fishbaugh PM, Welch WR, Muto MG, Berkowitz RS, Tsao SW. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res. 1993 Apr 1; 53(7):1489-92.
    View in: PubMed
  254. Berkowitz RS. CA125 measurement in epithelial ovarian cancer: a 10-year anniversary of clinical investigation. Gynecol Oncol. 1993 Apr; 49(1):1-2.
    View in: PubMed
  255. Tsao SW, Mok CH, Knapp RC, Oike K, Muto MG, Welch WR, Goodman HM, Sheets EE, Berkowitz RS, Lau CC. Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas. Gynecol Oncol. 1993 Jan; 48(1):5-10.
    View in: PubMed
  256. Fulop V, Feinberg BB, Steller MA, Anderson DJ, Berkowitz RS. Molar villous fluid suppresses mononuclear cell cytotoxicity. Gynecol Oncol. 1992 Dec; 47(3):311-6.
    View in: PubMed
  257. Goodman HM, Harlow BL, Sheets EE, Muto MG, Brooks S, Steller M, Knapp RC, Berkowitz RS. The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinoma. Gynecol Oncol. 1992 Sep; 46(3):367-71.
    View in: PubMed
  258. Berkowitz RS. Gestational trophoblastic diseases: recent advances in the understanding of cytogenetics, histopathology, and natural history. Curr Opin Obstet Gynecol. 1992 Aug; 4(4):616-20.
    View in: PubMed
  259. Fulop V, Steller MA, Berkowitz RS, Anderson DJ. Interferon-gamma receptors on human gestational choriocarcinoma cell lines: quantitative and functional studies. Am J Obstet Gynecol. 1992 Aug; 167(2):524-30.
    View in: PubMed
  260. Rice LW, Lage JM, Berkowitz RS, Goodman A, Muto MG, Knapp RC, Bell DA. Preoperative serum CA-125 levels in borderline tumors of the ovary. Gynecol Oncol. 1992 Aug; 46(2):226-9.
    View in: PubMed
  261. Wenzel L, Berkowitz R, Robinson S, Bernstein M, Goldstein D. The psychological, social, and sexual consequences of gestational trophoblastic disease. Gynecol Oncol. 1992 Jul; 46(1):74-81.
    View in: PubMed
  262. Lage JM, Mark SD, Roberts DJ, Goldstein DP, Bernstein MR, Berkowitz RS. A flow cytometric study of 137 fresh hydropic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy. Obstet Gynecol. 1992 Mar; 79(3):403-10.
    View in: PubMed
  263. Tsao SW, Mok CH, Oike K, Muto M, Goodman HM, Sheets EE, Berkowitz RS, Knapp RC, Lau CC. Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors. Anticancer Res. 1991 Nov-Dec; 11(6):1975-82.
    View in: PubMed
  264. Genest DR, Laborde O, Berkowitz RS, Goldstein DP, Bernstein MR, Lage J. A clinicopathologic study of 153 cases of complete hydatidiform mole (1980-1990): histologic grade lacks prognostic significance. Obstet Gynecol. 1991 Sep; 78(3 Pt 1):402-9.
    View in: PubMed
  265. Lage JM, Berkowitz RS, Rice LW, Goldstein DP, Bernstein MR, Weinberg DS. Flow cytometric analysis of DNA content in partial hydatidiform moles with persistent gestational trophoblastic tumor. Obstet Gynecol. 1991 Jan; 77(1):111-5.
    View in: PubMed
  266. Berkowitz RS, Goldstein DP, Bernstein MR. Reproductive experience after complete and partial molar pregnancy and gestational trophoblastic tumors. J Reprod Med. 1991 Jan; 36(1):3-8.
    View in: PubMed
  267. Muto MG, Lage JM, Berkowitz RS, Goldstein DP, Bernstein MR. Gestational trophoblastic disease of the fallopian tube. J Reprod Med. 1991 Jan; 36(1):57-60.
    View in: PubMed
  268. DuBeshter B, Berkowitz RS, Goldstein DP, Bernstein MR. Management of low-risk metastatic gestational trophoblastic tumors. J Reprod Med. 1991 Jan; 36(1):36-9.
    View in: PubMed
  269. Dobkin GR, Berkowitz RS, Goldstein DP, Bernstein MR, Doubilet PM. Duplex ultrasonography for persistent gestational trophoblastic tumor. J Reprod Med. 1991 Jan; 36(1):14-6.
    View in: PubMed
  270. Berkowitz RS, Goldstein DP, Bernstein MR. Evolving concepts of molar pregnancy. J Reprod Med. 1991 Jan; 36(1):40-4.
    View in: PubMed
  271. Rice LW, Genest DR, Berkowitz RS, Goldstein DP, Bernstein MR, Redline RW. Pathologic features of sharp curettings in complete hydatidiform mole. Predictors of persistent gestational trophoblastic disease. J Reprod Med. 1991 Jan; 36(1):17-20.
    View in: PubMed
  272. Rice LW, Berkowitz RS, Mark SD, Yavner DL, Lage JM. Epithelial ovarian tumors of borderline malignancy. Gynecol Oncol. 1990 Nov; 39(2):195-8.
    View in: PubMed
  273. Berkowitz RS. Recent advances in the biology and treatment of gestational trophoblastic diseases and germ cell tumors. Curr Opin Oncol. 1990 Oct; 2(5):901-5.
    View in: PubMed
  274. Leff J, Berkowitz R, Shavit N, Strachan A, Glass I, Vaughn C. A trial of family therapy versus a relatives' group for schizophrenia. Two-year follow-up. Br J Psychiatry. 1990 Oct; 157:571-7.
    View in: PubMed
  275. Berkowitz RS, Faris HM, Hill JA, Anderson DJ. Localization of leukocytes and cytokines in chorionic villi of normal placentas and complete hydatidiform moles. Gynecol Oncol. 1990 Jun; 37(3):396-400.
    View in: PubMed
  276. Rice LW, Berkowitz RS, Lage JM, Goldstein DP, Bernstein MR. Persistent gestational trophoblastic tumor after partial hydatidiform mole. Gynecol Oncol. 1990 Mar; 36(3):358-62.
    View in: PubMed
  277. Alvarez M, Berkowitz R. Multifetal gestation. Clin Obstet Gynecol. 1990 Mar; 33(1):79-87.
    View in: PubMed
  278. Berkowitz RS, Goldstein DP, Bernstein MR. Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors. Gynecol Oncol. 1990 Jan; 36(1):56-9.
    View in: PubMed
  279. Sumers EH, Berkowitz RS, Wang AM, Drum DE, Goldstein DP. Hepatic scintigraphic changes associated with gestational trophoblastic disease. Eur J Nucl Med. 1990; 16(8-10):721-3.
    View in: PubMed
  280. Berkowitz RS, Goldstein DP. Gestational trophoblastic diseases. Semin Oncol. 1989 Oct; 16(5):410-6.
    View in: PubMed
  281. Berkowitz RS. Gestational trophoblastic tumors and malignant ovarian germ cell tumors. Curr Opin Oncol. 1989 Oct; 1(1):119-22.
    View in: PubMed
  282. Rice LW, Lage JM, Berkowitz RS, Goldstein DP, Bernstein MR. Repetitive complete and partial hydatidiform mole. Obstet Gynecol. 1989 Aug; 74(2):217-9.
    View in: PubMed
  283. Berkowitz R, Ozturk M, Goldstein D, Bernstein M, Hill L, Wands JR. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles. Obstet Gynecol. 1989 Aug; 74(2):212-6.
    View in: PubMed
  284. Fine C, Bundy AL, Berkowitz RS, Boswell SB, Berezin AF, Doubilet PM. Sonographic diagnosis of partial hydatidiform mole. Obstet Gynecol. 1989 Mar; 73(3 Pt 1):414-8.
    View in: PubMed
  285. DuBeshter B, Berkowitz RS, Goldstein DP, Bernstein M. Vinblastine, cisplatin and bleomycin as salvage therapy for refractory high-risk metastatic gestational trophoblastic disease. J Reprod Med. 1989 Mar; 34(3):189-92.
    View in: PubMed
  286. Leff J, Berkowitz R, Shavit N, Strachan A, Glass I, Vaughn C. A trial of family therapy v. a relatives group for schizophrenia. Br J Psychiatry. 1989 Jan; 154:58-66.
    View in: PubMed
  287. Berkowitz RS, Goldstein DP. Diagnosis and management of the primary hydatidiform mole. Obstet Gynecol Clin North Am. 1988 Sep; 15(3):491-503.
    View in: PubMed
  288. Smith PJ, Wise LS, Berkowitz R, Wan C, Rubin CS. Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem. 1988 Jul 5; 263(19):9402-8.
    View in: PubMed
  289. Finkler NJ, Berkowitz RS, Driscoll SG, Goldstein DP, Bernstein MR. Clinical experience with placental site trophoblastic tumors at the New England Trophoblastic Disease Center. Obstet Gynecol. 1988 Jun; 71(6 Pt 1):854-7.
    View in: PubMed
  290. DuBeshter B, Berkowitz RS, Goldstein DP, Bernstein MR. Analysis of treatment failure in high-risk metastatic gestational trophoblastic disease. Gynecol Oncol. 1988 Feb; 29(2):199-207.
    View in: PubMed
  291. Berkowitz RS, Umpierre SA, Goldstein DP, Anderson DJ. Cross-reactivity of monoclonal antibodies directed against lymphocyte markers with trophoblast cells of normal placenta, hydatidiform mole, and gestational choriocarcinoma. Gynecol Oncol. 1988 Jan; 29(1):94-100.
    View in: PubMed
  292. Ozturk M, Berkowitz R, Goldstein D, Bellet D, Wands JR. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease. Am J Obstet Gynecol. 1988 Jan; 158(1):193-8.
    View in: PubMed
  293. Berkowitz RS, Hill JA, Kurtz CB, Anderson DJ. Effects of products of activated leukocytes (lymphokines and monokines) on the growth of malignant trophoblast cells in vitro. Am J Obstet Gynecol. 1988 Jan; 158(1):199-203.
    View in: PubMed
  294. Berkowitz RS, Goldstein DP, Bernstein MR, Sablinska B. Subsequent pregnancy outcome in patients with molar pregnancy and gestational trophoblastic tumors. J Reprod Med. 1987 Sep; 32(9):680-4.
    View in: PubMed
  295. Berkowitz RS, Goldstein DP, DuBeshter B, Bernstein MR. Management of complete molar pregnancy. J Reprod Med. 1987 Sep; 32(9):634-9.
    View in: PubMed
  296. Mostoufi-Zadeh M, Berkowitz RS, Driscoll SG. Persistence of partial mole. Am J Clin Pathol. 1987 Mar; 87(3):377-80.
    View in: PubMed
  297. DuBeshter B, Berkowitz RS, Goldstein DP, Cramer DW, Bernstein MR. Metastatic gestational trophoblastic disease: experience at the New England Trophoblastic Disease Center, 1965 to 1985. Obstet Gynecol. 1987 Mar; 69(3 Pt 1):390-5.
    View in: PubMed
  298. Berkowitz RS, Umpierre SA, Johnson PM, McIntyre JA, Anderson DJ. Expression of trophoblast-leukocyte common antigens and placental-type alkaline phosphatase in complete molar pregnancy. Am J Obstet Gynecol. 1986 Aug; 155(2):443-6.
    View in: PubMed
  299. Osathanondh R, Berkowitz RS, de Cholnoky C, Smith BS, Goldstein DP, Tyson JE. Hormonal measurements in patients with theca lutein cysts and gestational trophoblastic disease. J Reprod Med. 1986 Mar; 31(3):179-83.
    View in: PubMed
  300. Berkowitz RS, Umpierre SA, Taylor-Emery S, Goldstein DP, Anderson DJ. Immunobiology of complete molar pregnancy and gestational trophoblastic tumor. Cancer Metastasis Rev. 1986; 5(2):109-23.
    View in: PubMed
  301. Berkowitz RS, Goldstein DP, Bernstein MR. Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol. 1986 Jan; 23(1):111-8.
    View in: PubMed
  302. Berkowitz RS, Alexander NJ, Goldstein DP, Anderson DJ. Reactivity of anti-human sperm monoclonal antibodies with normal placenta, hydatidiform mole, and gestational choriocarcinoma. Gynecol Oncol. 1985 Nov; 22(3):334-40.
    View in: PubMed
  303. Berkowitz RS, Goldstein DP, Bernstein MR. Natural history of partial molar pregnancy. Obstet Gynecol. 1985 Nov; 66(5):677-81.
    View in: PubMed
  304. Anderson DJ, Berkowitz RS. Gamma-interferon enhances expression of Class I MHC antigens in the weakly HLA+ human choriocarcinoma cell line BeWo, but does not induce MHC expression in the HLA- choriocarcinoma cell line Jar. J Immunol. 1985 Oct; 135(4):2498-501.
    View in: PubMed
  305. Berkowitz RS, Cramer DW, Bernstein MR, Cassells S, Driscoll SG, Goldstein DP. Risk factors for complete molar pregnancy from a case-control study. Am J Obstet Gynecol. 1985 Aug 15; 152(8):1016-20.
    View in: PubMed
  306. Berek JS, Knapp RC, Hacker NF, Lichtenstein A, Jung T, Spina C, Obrist R, Griffiths CT, Berkowitz RS, Parker L, et al. Intraperitoneal immunotherapy of epithelial ovarian carcinoma with Corynebacterium parvum. Am J Obstet Gynecol. 1985 Aug 15; 152(8):1003-10.
    View in: PubMed
  307. Leff J, Kuipers L, Berkowitz R, Sturgeon D. A controlled trial of social intervention in the families of schizophrenic patients: two year follow-up. Br J Psychiatry. 1985 Jun; 146:594-600.
    View in: PubMed
  308. Kabawat SE, Mostoufi-Zadeh M, Berkowitz RS, Driscoll SG, Goldstein DP, Bhan AK. Implantation site in complete molar pregnancy: a study of immunologically competent cells with monoclonal antibodies. Am J Obstet Gynecol. 1985 May 1; 152(1):97-9.
    View in: PubMed
  309. Romero R, Jeanty P, Reece EA, Grannum P, Bracken M, Berkowitz R, Hobbins JC. Sonographically monitored amniocentesis to decrease intraoperative complications. Obstet Gynecol. 1985 Mar; 65(3):426-30.
    View in: PubMed
  310. Zucker PK, Berkowitz RS. The issue of microinvasive squamous cell carcinoma of the vulva: an evaluation of the criteria of diagnosis and methods of therapy. Obstet Gynecol Surv. 1985 Mar; 40(3):136-43.
    View in: PubMed
  311. Berkowitz RS, Alberti O, Hunter NJ, Goldstein DP, Anderson DJ. Localization of stage-specific embryonic antigens in hydatidiform mole, normal placenta, and gestational choriocarcinoma. Gynecol Oncol. 1985 Jan; 20(1):71-7.
    View in: PubMed
  312. Berkowitz RS, Dubey DP, Goldstein DP, Anderson DJ. Localization of transferrin receptor in the chorionic villi of complete molar pregnancy. Am J Obstet Gynecol. 1985 Jan 1; 151(1):128-9.
    View in: PubMed
  313. Amir SM, Osathanondh R, Berkowitz RS, Goldstein DP. Human chorionic gonadotropin and thyroid function in patients with hydatidiform mole. Am J Obstet Gynecol. 1984 Nov 15; 150(6):723-8.
    View in: PubMed
  314. Goldstein DP, Berkowitz RS. Staging system for gestational trophoblastic tumors. J Reprod Med. 1984 Nov; 29(11):792-5.
    View in: PubMed
  315. Berkowitz RS, Goldstein DP, Hoch EJ, Anderson DJ. Immunobiology of molar pregnancy and gestational trophoblastic tumors. J Reprod Med. 1984 Nov; 29(11):796-801.
    View in: PubMed
  316. Berkowitz RS, Goldstein DP, Bernstein MR. Modified triple chemotherapy in the management of high-risk metastatic gestational trophoblastic tumors. Gynecol Oncol. 1984 Oct; 19(2):173-81.
    View in: PubMed
  317. Berkowitz RS, Hoch EJ, Goldstein DP, Anderson DJ. Histocompatibility antigens (HLA-A,B,C) are not detectable in molar villous fluid. Gynecol Oncol. 1984 Sep; 19(1):74-8.
    View in: PubMed
  318. Lahey SJ, Steele G, Berkowitz R, Rodrick ML, Ross DS, Goldstein DP, Zamcheck N, Wilson RE, Deasy JM. Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia. J Natl Cancer Inst. 1984 May; 72(5):983-90.
    View in: PubMed
  319. Leff J, Kuipers L, Berkowitz R, Eberlein-Fries R, Sturgeon D. Psychosocial relevance and benefit of neuroleptic maintenance: experience in the United Kingdom. J Clin Psychiatry. 1984 May; 45(5 Pt 2):43-9.
    View in: PubMed
  320. Lahey SJ, Steele G, Rodrick ML, Berkowitz R, Goldstein DP, Ross DS, Ravikumar TS, Wilson RE, Byrn R, Thomas P, et al. Characterization of antigenic components from circulating immune complexes in patients with gestational trophoblastic neoplasia. Cancer. 1984 Mar 15; 53(6):1316-21.
    View in: PubMed
  321. Goldstein DP, Berkowitz RS, Bernstein MR. Reproductive performance after molar pregnancy and gestational trophoblastic tumors. Clin Obstet Gynecol. 1984 Mar; 27(1):221-7.
    View in: PubMed
  322. Goldstein DP, Berkowitz RS. The role of regional centers for gestational trophoblastic disease. Adv Exp Med Biol. 1984; 176:383-400.
    View in: PubMed
  323. Berkowitz RS, Goldstein DP, Bernstein MR. Choriocarcinoma following term gestation. Gynecol Oncol. 1984 Jan; 17(1):52-7.
    View in: PubMed
  324. Bast RC, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parker L, Zurawski VR, Knapp RC. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983 Oct 13; 309(15):883-7.
    View in: PubMed
  325. Berkowitz R, Kabawat S, Lazarus H, Colvin R, Knapp R, Bast RC. Comparison of a rabbit heteroantiserum and a murine monoclonal antibody raised against a human epithelial ovarian carcinoma cell line. Am J Obstet Gynecol. 1983 Jul 15; 146(6):607-12.
    View in: PubMed
  326. Berkowitz RS, Birnholz J, Goldstein DP, Bernstein MR. Pelvic ultrasonography and the management of gestational trophoblastic disease. Gynecol Oncol. 1983 Jun; 15(3):403-12.
    View in: PubMed
  327. Berkowitz RS, Anderson DJ, Hunter NJ, Goldstein DP. Distribution of major histocompatibility (HLA) antigens in chorionic villi of molar pregnancy. Am J Obstet Gynecol. 1983 May 15; 146(2):221-2.
    View in: PubMed
  328. Bast RC, Berek JS, Obrist R, Griffiths CT, Berkowitz RS, Hacker NF, Parker L, Lagasse LD, Knapp RC. Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvum. Cancer Res. 1983 Mar; 43(3):1395-401.
    View in: PubMed
  329. Berkowitz RS, Lahey SJ, Rodrick ML, Rayner AA, Goldstein DP, Steele G. Circulating immune complex levels in patients with molar pregnancy. Obstet Gynecol. 1983 Feb; 61(2):165-8.
    View in: PubMed
  330. Berkowitz RS. Immunopathologic study of the implantation site in molar pregnancy. Am J Obstet Gynecol. 1982 Dec 15; 144(8):925-30.
    View in: PubMed
  331. Berkowitz RS, Goldstein DP, Bernstein MR. Methotrexate with citrovorum factor rescue as primary therapy for gestational trophoblastic disease. Cancer. 1982 Nov 15; 50(10):2024-7.
    View in: PubMed
  332. Berkowitz RS, Sandstrom M, Goldstein DP, Driscoll SG. 45,X complete hydatidiform mole. Gynecol Oncol. 1982 Oct; 14(2):279-83.
    View in: PubMed
  333. Leff J, Kuipers L, Berkowitz R, Eberlein-Vries R, Sturgeon D. A controlled trial of social intervention in the families of schizophrenic patients. Br J Psychiatry. 1982 Aug; 141:121-34.
    View in: PubMed
  334. Rayner AA, Berkowitz R, Steele G, Schur PH, Rodrick ML, Goldstein DP, Harte PJ, Wilson RE, Zamcheck N, Munroe AE. Circulating immune complex levels in patients with gestational trophoblastic neoplasia. J Natl Cancer Inst. 1982 Jul; 69(1):23-6.
    View in: PubMed
  335. Goldstein DP, Berkowitz RS. Nonmetastatic and low-risk metastatic gestational trophoblastic neoplasms. Semin Oncol. 1982 Jun; 9(2):191-7.
    View in: PubMed
  336. Goldstein DP, Berkowitz RS, Kosasa TS. Measurement of human chorionic gonadotropin. Major Probl Obstet Gynecol. 1982; 14:64-97.
    View in: PubMed
  337. Goldstein DP, Berkowitz RS. Gestational trophoblastic neoplasms. Clinical principles of diagnosis and management. Major Probl Obstet Gynecol. 1982; 14:1-301.
    View in: PubMed
  338. Berkowitz RS, Osathanondh R, Goldstein DP, Martin PM, Mallampati SR, Datta S. Cerebrospinal fluid human chorionic gonadotropin levels in normal pregnancy and choriocarcinoma. Surg Gynecol Obstet. 1981 Nov; 153(5):687-9.
    View in: PubMed
  339. Berkowitz RS, Goldstein DP, Marean AR, Bernstein M. Oral contraceptives and postmolar trophoblastic disease. Obstet Gynecol. 1981 Oct; 58(4):474-7.
    View in: PubMed
  340. Berkowitz RS, Goldstein DP, Bernstein MR. Management of nonmetastatic trophoblastic tumors. J Reprod Med. 1981 Apr; 26(4):219-22.
    View in: PubMed
  341. Berkowitz RS, Goldstein DP, Bernstein MR. Horizons in the management of gestational trophoblastic neoplasia: analysis of treatment failure. J Reprod Med. 1981 Apr; 26(4):227-9.
    View in: PubMed
  342. Goldstein DP, Berkowitz RS, Bernstein MR. Management of molar pregnancy. J Reprod Med. 1981 Apr; 26(4):208-12.
    View in: PubMed
  343. Kirschner MA, Lippman A, Berkowitz R, Mayrer E, Drejka M. Estrogen production as a tumor marker in patients with gonadotropin-producing neoplasms. Cancer Res. 1981 Apr; 41(4):1447-50.
    View in: PubMed
  344. Berkowitz RS, Goldstein DP. Pathogenesis of gestational trophoblastic neoplasms. Pathobiol Annu. 1981; 11:391-411.
    View in: PubMed
  345. Berkowitz RS, Hornig-Rohan J, Martin-Alosco S, Klein S, Goldstein DP, Bast RC, DeWolf WC. HL-A antigen frequency distribution in patients with gestational choriocarcinoma and their husbands. Placenta Suppl. 1981; 3:263-7.
    View in: PubMed
  346. Berkowitz RS, Marean AR, Goldstein DP, Bernstein MR. Oral contraceptives and post-molar trophoblastic tumours. Lancet. 1980 Oct 4; 2(8197):752.
    View in: PubMed
  347. Berkowitz RS, Desai U, Goldstein DP, Driscoll SG, Marean AR, Bernstein MR. Pretreatment curettage-A predictor of chemotherapy response in gestational trophoblastic neoplasia. Gynecol Oncol. 1980 Aug; 10(1):39-43.
    View in: PubMed
  348. Berkowitz RS, Marean AR, Hamilton N, Bernstein M, Engle RP, Sandman G, Goldstein DP. Psychological and social impact of gestational trophoblastic neoplasia. J Reprod Med. 1980 Jul; 25(1):14-6.
    View in: PubMed
  349. Pais SO, Glickman M, Schwartz P, Pingoud E, Berkowitz R. Embolization of pelvic arteries for control of postpartum hemorrhage. Obstet Gynecol. 1980 Jun; 55(6):754-8.
    View in: PubMed
  350. Berkowitz RS, Goldstein DP, Bernstein MR. Laparoscopy in the management of gestational trophoblastic neoplasms. J Reprod Med. 1980 Jun; 24(6):261-4.
    View in: PubMed
  351. Federschneider JM, Goldstein DP, Berkowitz RS, Marean AR, Bernstein MR. Natural history of recurrent molar pregnancy. Obstet Gynecol. 1980 Apr; 55(4):457-9.
    View in: PubMed
  352. Berkowitz RS, Goldstein DP, Jones MA, Marean AR, Bernstein MR. Methotrexate with citrovorum factor rescue: reduced chemotherapy toxicity in the management of gestational trophoblastic neoplasms. Cancer. 1980 Feb; 45(3):423-6.
    View in: PubMed
  353. Berkowitz RS, Goldstein DP. Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms. Obstet Gynecol. 1979 Dec; 54(6):725-8.
    View in: PubMed
  354. Berkowitz RS, Ehrmann RL, Lavizzo-Mourey R, Knapp RC. Invasive cervical carcinoma in young women. Gynecol Oncol. 1979 Dec; 8(3):311-6.
    View in: PubMed
  355. Berkowitz RS, Goldstein DP, Marean AR, Bernstein MR. Proliferative sequelae after evacuation of partial hydatidiform mole. Lancet. 1979 Oct 13; 2(8146):804-5.
    View in: PubMed
  356. Schneider G, Kirschner MA, Berkowitz R, Ertel NH. Increased estrogen production in obese men. J Clin Endocrinol Metab. 1979 Apr; 48(4):633-8.
    View in: PubMed
  357. Berkowitz RS, Goldstein DP, Bernstein M. Natural history of partial hydatidiform moles. Lancet. 1979 Mar 31; 1(8118):719.
    View in: PubMed
  358. Berkowitz RS, Leavitt T, Knapp RC. Ultrasound-directed percutaneous aspiration biopsy of periaortic lymph nodes in recurrence of cervical carcinoma. Am J Obstet Gynecol. 1978 Aug 15; 131(8):906-8.
    View in: PubMed
  359. Mayer RJ, Berkowitz RS, Griffiths CT. Central nervous system involvement by ovarian carcinoma: a complication of prolonged survivial with metastatic disease. Cancer. 1978 Feb; 41(2):776-83.
    View in: PubMed
  360. Berkowitz RS, Ehrmann RL, Knapp RC. Endometrial stromal sarcoma arising from vaginal endometriosis. Obstet Gynecol. 1978 Jan; 51(1 Suppl):34s-37s.
    View in: PubMed
  361. Knapp RC, Berkowitz RS. Corynebacterium parvum as an immunotherapeutic agent in an ovarian cancer model. Am J Obstet Gynecol. 1977 Aug 1; 128(7):782-6.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Berkowitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_